Mylan Tamsulosin 0,4 mg

Tamsulosin Mylan generics 0,4 mg modified-release hard capsules is a generic medication containing tamsulosin hydrochloride, primarily prescribed for the symptomatic treatment of benign prostatic hyperplasia (BPH).

The Mylan brand traces its origins back to 1961, when it was founded as Milan Pharmaceuticals in White Sulphur Springs, West Virginia, United States. Over several decades, Mylan developed into one of the world's leading suppliers of generic pharmaceuticals and active pharmaceutical ingredients.

In November 2020, Mylan N.V. merged with Pfizer's off-patent and generic medicine business, Upjohn, to form Viatris Inc., a global healthcare company headquartered in Canonsburg, Pennsylvania, United States (visible by the Viatris logo on the bottom right corner of the packaging). In Italy, the product is distributed and marketed by the local subsidiary, Mylan S.p.A. (a Viatris company), with manufacturing carried out across specialized production facilities in Europe and internationally.